As of 2026-09-08, the Relative Valuation of Apellis Pharmaceuticals Inc (APLS) is 22.94 USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.03 USD, the upside of Apellis Pharmaceuticals Inc based on Relative Valuation is -44.1%.
The range of the Relative Valuation is 8.62 - 38.83 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.5x - 37.3x | 34.4x |
| Forward P/E multiples | 32.2x - 43.0x | 37.6x |
| Fair Price | 8.62 - 38.83 | 22.94 |
| Upside | -79.0% - -5.4% | -44.1% |
| Date | P/E |